Clinical and Translational Medicine (Sep 2023)
Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities
Abstract
No abstracts available.
Clinical and Translational Medicine (Sep 2023)